Wall Street analysts typically cover a multitude of stocks, giving their opinion on whether they are a buy or sell. The most popular ones, however, tend to get the most coverage. Because of that, several good companies often slip through the cracks.
Three stocks that don't seem to have caught Wall Street's attention yet are online bank Ally Financial (NYSE:ALLY), pharmaceutical company UroGen Pharma (NASDAQ:URGN), and midstream MLP Noble Midstream Partners (NYSE:NBLX). Here's why our contributors don't want you to miss them, too.